Abstract
The study’s objective was to examine variations in viral load (VL) suppression definitions among clients in the Ryan White Program (RWP). Data from clients enrolled in the RWP during 2017 were examined to calculate the proportion of virally suppressed clients using three definitions: recent viral suppression, defined as having a suppressed VL (< 200 copies/mL) in the last test in 2017; maintained viral suppression, having a suppressed VL for both the first and last tests in 2017; and sustained viral suppression, having all tests in 2017 showing suppression. Relative differences across all three definitions were computed. Recent viral suppression measures were higher than maintained and sustained viral suppression measures by 7.0% and 10.1%, respectively. Significant relative differences in definitions by demographic, socioeconomic and clinical status were observed. It may be beneficial for care planning to report not only estimates of recent viral suppression but maintained and sustained viral suppression as well.
Similar content being viewed by others
Abbreviations
- ACA:
-
Affordable Care Act
- AC1:
-
Gwet’s agreement coefficient
- AOR:
-
Adjusted odds ratio
- ART:
-
Antiretroviral therapy
- CI:
-
Confidence interval
- FPL:
-
Federal Poverty Level
- IDU:
-
Injection drug use
- MSM:
-
Male-to-male sexual contact
- NHB:
-
Non-Hispanic Black
- NHW:
-
Non-Hispanic White
- NPV:
-
Negative predictive value
- PPV:
-
Positive predictive value
- PWH:
-
People with HIV
- RWP:
-
Ryan White Program
- VL:
-
Viral load
References
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493–505.
Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med. 2000;342:921–9.
Mugavero MJ, Napravnik S, Cole SR, Eron JJ, Lau B, Crane HM, et al. Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy. Clin Infect Dis. 2011;53:927–35.
Murray JS, Elashoff MR, Iacono-Connors LC, Cvetkovich TA, Struble KA. The use of plasma HIV RNA as a study endpoint in efficacy trials of antiretroviral drugs. AIDS. 1999;13:797–804.
Marschner IC, Collier AC, Coombs RW, D’Aquila RT, DeGruttola V, Fischl MA, et al. Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy. J Infect Dis. 1998;177:40–7.
May MT, Gompels M, Delpech V, Porter K, Orkin C, Kegg S, et al. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. AIDS. 2014;28:1193–202.
Crepaz N, Dong X, Hess KL, Bosh K. Brief report: racial and ethnic disparities in sustained viral suppression and transmission risk potential among persons aged 13–29 years living with diagnosed HIV infection, United States, 2016. J Acquir Immune Defic Syndr. 2020;83:334–9.
Crepaz N, Dong X, Wang X, Hernandez AL, Hall HI. Racial and ethnic disparities in sustained viral suppression and transmission risk potential among persons receiving HIV care - United States, 2014. MMWR Morb Mortal Wkly Rep. 2018;67:113–8.
Health Resources and Services Administration. About the Ryan White HIV/AIDS Program [Internet]. Available from: https://hab.hrsa.gov/about-ryan-white-hivaids-program/about-ryan-white-hivaids-program
U.S. Department of Health and Human Services. HIV National Strategic Plan for the United States: A roadmap to end the epidemic 2021–2025. Washington, DC; 2021
Department of Health and Human Services. Panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV [Internet]. 2019 [cited 2019 Nov 2]. p. 298. Available from: https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf
Marks G, Patel U, Stirratt MJ, Mugavero MJ, Mathews WC, Giordano TP, et al. Single viral load measurements overestimate stable viral suppression among HIV patients in care: clinical and public health implications. J Acquir Immune Defic Syndr. 2016;73:205–12.
Sheehan DM, Dawit R, Gbadamosi SO, Fennie KP, Li T, Gebrezgi M, et al. Sustained HIV viral suppression among men who have sex with men in the Miami-Dade County Ryan White Program: the effect of demographic, psychosocial, provider and neighborhood factors. BMC Public Health. 2020;20:326.
Crepaz N, Tang T, Marks G, Hall HI. Changes in viral suppression status among US HIV-infected patients receiving care. AIDS. 2017;31:2421–5.
Skarbinski J, Rosenberg E, Paz-Bailey G, Hall HI, Rose CE, Viall AH, et al. Human immunodeficiency virus transmission at each step of the care continuum in the United States. JAMA Intern Med. 2015;175:588–96.
Percus JK, Percus OE, Di Mascio M. The amplitudes of viral blips in HIV-1 infected patients treated with antiretroviral therapy are power-law distributed. J Theor Biol. 2009;257:454–9.
Hull MW, Lima VD, Hogg RS, Harrigan PR, Montaner JSG. Epidemiology of treatment failure: a focus on recent trends. Curr Opin HIV AIDS. 2009;4:467–73.
Althoff KN, Rebeiro P, Brooks JT, Buchacz K, Gebo K, Martin J, et al. Disparities in the quality of HIV care when using US Department of Health and Human Services indicators. Clin Infect Dis. 2014;58:1185–9.
Novak RM, Hart RLD, Chmiel JS, Brooks JT, Buchacz K. Disparities in initiation of combination antiretroviral treatment and in virologic suppression among patients in the HIV Outpatient Study, 2000–2013. J Acquir Immune Defic Syndr US. 2015;70:23–32.
Haines CF, Fleishman JA, Yehia BR, Lau B, Berry SA, Agwu AL, et al. Closing the gap in antiretroviral initiation and viral suppression: time trends and racial disparities. J Acquir Immune Defic Syndr. 2016;73:340–7.
Beer L, Mattson CL, Bradley H, Skarbinski J. Understanding cross-sectional racial, ethnic, and gender disparities in antiretroviral use and viral suppression among HIV patients in the United States. Medicine (Baltimore). 2016;95: e3171.
Health Resources and Services Administration. Ryan White HIV/AIDS Program Annual Client-Level Data Report 2019 [Internet]. 2020. Available from: https://hab.hrsa.gov/data/data-reports. Accessed 4 April 2021
Centers for Disease Control and Prevention. HIV surveillance report, 2018 (Updated); vol. 31. 2020. Available from: https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2018-updated-vol-31.pdf
Centers for Disease Control and Prevention. Diagnoses of HIV infection among adults and adolescents in metropolitan statistical areas—United States and Puerto Rico, 2017. HIV Surveill Suppl Rep 2019;24(No 2). 2019. Available from: http://www.cdc.gov/hiv/library/reports/hivsurveillance.html
Florida Department of Health. Surveillance: Fact sheets. Available from: http://www.floridahealth.gov/diseases-and-conditions/aids/surveillance/_documents/fact-sheet/Miami_Dade_County_Factsheet_ten_years.pdf. Accessed 16 March 2016
Miami-Dade HIV/AIDS Partnership. 2020 Needs Assessment: Ryan White Program Year 31. 2019. Available from: http://aidsnet.org/wp-content/uploads/2020/08/2020-Needs-Assessment-Book-7-2-20-version-FINAL-read-version.pdf. Accessed 12 Dec 2021
Miami-Dade County Office of Management and Budget Grants. Ryan White Program Service Delivery Guidelines Fiscal Year 2016. 2016. Available from: https://www.miamidade.gov/grants/library/ryanwhite/service-delivery-section-I-2016.pdf. Accessed 12 Dec 2021
2017–2021 CDC/HRSA Integrated HIV/AIDS Prevention and Care Plan. 2016. Available from: https://www.testmiami.org/static/sitefiles/documents/Miami_EMA_-_Integrated_Plan_-_Narrative_9-19-16_final.pdf
Centers for Disease Control and Prevention. Terms, definitions, and calculations used in CDC HIV surveillance publications. 2019. Available from: https://www.cdc.gov/hiv/statistics/surveillance/terms.html. Accessed 4 April 2021
SAS Institute Inc. SAS/STAT® 142 user’s guide. Cary, NC: SAS Institute Inc; 2016.
Gwet KL. Handbook of inter-rater reliability: The definitive guide to measuring the extent of agreement among raters. Advanced Analytics, LLC; 2014.
Font H, Rollins N, Essajee S, Becquet R, Foster G, Mangwiro AZ, et al. Retention-in-care in the PMTCT cascade: definitions matter! Analyses from the INSPIRE projects in Malawi, Nigeria and Zimbabwe. J Int AIDS Soc. 2020;23: e25609.
Sani AS, Abraham C, Denford S, Ball S. School-based sexual health education interventions to prevent STI/HIV in sub-Saharan Africa: a systematic review and meta-analysis. BMC Public Health. 2016;16:1–26.
Ssewanyana D, Van Baar A, Newton CR, Abubakar A. A contextually relevant approach to assessing health risk behavior in a rural sub-Saharan Africa setting: the Kilifi health risk behavior questionnaire. BMC Public Health. 2018;18:774.
Feinstein AR, Cicchetti DV. High agreement but low Kappa: I. the problems of two paradoxes. J Clin Epidemiol. 1990;43:543–9.
Cicchetti DV, Feinstein AR. High agreement but low kappa: II. Resolving the paradoxes. J Clin Epidemiol US. 1990;43:551–8.
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.
Talih M, Huang D. Measuring progress toward target attainment and the elimination of health disparities in Healthy People 2020. Healthy People Statistical Notes, no 27.. 2016. Available from: https://www.cdc.gov/nchs/data/statnt/statnt27.pdf. Accessed 12 Dec 2021
Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol. 1989;129:125–37.
Das M, Chu PL, Santos G-M, Scheer S, Vittinghoff E, McFarland W, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS ONE. 2010;5: e11068.
Henard S, Jeanmaire E, Nguyen Y, Yazdanpanah Y, Cheret A, Hoen B, et al. Is total community viral load a robust predictive marker of the efficacy of the TasP strategy? J Acquir Immune Defic Syndr. 2012;61:400–2.
Montaner JSG, Lima VD, Barrios R, Yip B, Wood E, Kerr T, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet. 2010;376:532–9.
Solomon SS, Mehta SH, McFall AM, Srikrishnan AK, Saravanan S, Laeyendecker O, et al. Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study. Lancet HIV. 2016;3:e183–90.
Chakraborty H, Weissman S, Duffus WA, Hossain A, Varma Samantapudi A, Iyer M, et al. HIV community viral load trends in South Carolina. Int J STD AIDS. 2017;28:265–76.
Nwangwu-Ike N, Frazier EL, Crepaz N, Tie Y, Sutton MY. Racial and ethnic differences in viral suppression among HIV-positive women in care. J Acquir Immune Defic Syndr. 2018;79:e56-68.
Bradley H, Mattson CL, Beer L, Huang P, Shouse RL. Medical Monitoring Project. Increased antiretroviral therapy prescription and HIV viral suppression among persons receiving clinical care for HIV infection. AIDS. 2016;30:2117–24.
Chowdhury P, Beer L, Shouse RL, Bradley H. Brief report: clinical outcomes of young black men receiving HIV medical care in the United States, 2009–2014. J Acquir Immune Defic Syndr US. 2019;81:5–9.
Sullivan PS, Knox J, Jones J, Taussig J, Valentine Graves M, Millett G, et al. Understanding disparities in viral suppression among Black MSM living with HIV in Atlanta Georgia. J Int AIDS Soc. 2021;24: e25689.
Vyavaharkar MV, Moneyham L, Corwin S. Health care utilization: the experiences of rural HIV-positive African American women. J Health Care Poor Underserved US. 2008;19:294–306.
Vyavaharkar M, Moneyham L, Corwin S, Saunders R, Annang L, Tavakoli A. Relationships between stigma, social support, and depression in HIV-infected African American women living in the rural Southeastern United States. J Assoc Nurses AIDS Care. 2010;21:144–52.
Dale S, Cohen M, Weber K, Cruise R, Kelso G, Brody L. Abuse and resilience in relation to HAART medication adherence and HIV viral load among women with HIV in the United States. AIDS Patient Care STDS. 2014;28:136–43.
Kelso GA, Cohen MH, Weber KM, Dale SK, Cruise RC, Brody LR. Critical consciousness, racial and gender discrimination, and HIV disease markers in African American women with HIV. AIDS Behav. 2014;18:1237–46.
Dale SK, Bogart LM, Wagner GJ, Galvan FH, Klein DJ. Medical mistrust is related to lower longitudinal medication adherence among African-American males with HIV. J Health Psychol. 2016;21:1311–21.
Gaston GB, Alleyne-Green B. The impact of African Americans’ beliefs about HIV medical care on treatment adherence: a systematic review and recommendations for interventions. AIDS Behav US. 2013;17:31–40.
Crepaz N, Tang T, Marks G, Mugavero MJ, Espinoza L, Hall HI. Durable viral suppression and transmission risk potential among persons with diagnosed HIV infection: United States, 2012–2013. Clin Infect Dis. 2016;63:976–83.
Buscher A, Mugavero M, Westfall AO, Keruly J, Moore R, Drainoni M-L, et al. The association of clinical follow-up intervals in HIV-infected persons with viral suppression on subsequent viral suppression. AIDS Patient Care STDS. 2013;27:459–66.
Thompson MA, Horberg MA, Agwu AL, Colasanti JA, Jain MK, Short WR, et al. Primary care guidance for persons with human immunodeficiency virus: 2020 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis US. 2021;73:e3572–605.
Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS. 2003;17:1871–9.
Pilcher CD, Joaki G, Hoffman IF, Martinson FEA, Mapanje C, Stewart PW, et al. Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS. 2007;21:1723–30.
Funding
Research reported in this publication was supported by awards from the National Institute on Minority Health & Health Disparities of K01MD013770, R01MD013563 and R01MD012421 and in part by F31MD015234 from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author information
Authors and Affiliations
Contributions
SOG, MJT, and DS conceptualized and designed the study. SOG analyzed the data. SOG wrote the original draft. MJT, RD, ZB, AR, RAL and DS reviewed the draft for intellectual content, contributed to the interpretation and presentation of the findings. All authors have read and approved the final version of the manuscript for submission.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare they have no financial interests.
Consent for Publication
N/A.
Ethical Approval
The study reported in this manuscript was approved by the Florida International University Institutional Review Board. Permission was required from Miami-Dade County to access the Ryan White Program data used in this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gbadamosi, S.O., Trepka, M.J., Dawit, R. et al. A Comparative Analysis of Different HIV Viral Load Suppression Definitions Among Clients Receiving Care in the Miami-Dade Ryan White HIV/AIDS Program. AIDS Behav 26, 3576–3588 (2022). https://doi.org/10.1007/s10461-022-03694-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-022-03694-6